tirzepatide cardiovascular outcomes study 💉 In a large real-world study, was associated with a lower incidence of major vs semaglutide: 📊 Composite CV outcome: 1.90% vs 2.18% (HR 0.86, p=0.01) ❤️ New-onset heart UC Irvine researchers project cardiac

Some studies indicate people with obesity have low vitamin B12 levels

While CGM data is often siloed, linking it with Truvetas rich clinical data allows for more comprehensive studies on the combined effects of GLP-1s and CGMs on glycemic control, treatment adherence, and overall patient outcomes

One study showed that In patients with type 2 diabetes inadequately controlled by metformin, dulaglutide at doses of 3.0 mg and 4.5 mg demonstrated significant and dose-related reductions in body weight compared to the 1.5 mg dose

& Faller, D

In the post-menpausal years women gain on average about 1.5 pounds per yearsome even more